No serious newspaper since 2026.956 channels · 7 languages · updated daily

The Daily Booger

BITCOIN256 voices17581GOLD243 voices16974S&P 500237 voices104133CRUDE OIL (WTI)181 voices15229NVDA163 voices11548SILVER145 voices8956US DOLLAR INDEX144 voices33111SEMICONDUCTORS (SMH)92 voices4745TSLA91 voices6031SK HYNIX87 voices6126ETHEREUM87 voices6918MU86 voices6422MSFT83 voices6815GOOGL81 voices641720+ YEAR TREASURIES (TLT)79 voices3643JPY=X74 voices4034SAMSUNG ELECTRONICS73 voices3835META73 voices5518
266,733videos·956channels analyzed·next analysis daily
← The board

Angel One Markets

Publishes in HI · 12 graded calls · YouTube ↗ ·
36*yuckyBooger Score · 50 is a coin flip

50 is a coin flip. Higher means a creator's past calls beat chance on the assets and periods they were made in; lower means they did worse.

A high score does not predict the next call. We tested whether it does, and it does not. We publish the ranking because the record should exist and be checkable. Our scoring is not financial advice and the method behind it is not published.

yucky — below luck. Provisional — too few graded calls to mean much. This does not predict their next call. We tested whether it does and it does not. Our scoring is not financial advice.

Most coveredIndian equities (broad market) 2Sky Gold 1Steelcast 1

30d record, oldest first

The record

16 calls · newest first · every one links to its source
2026-08-27SteelcastSTEELCAS.NS▲ up

2 Smallcap Stocks With Explosive Profit Growth

Steelcast highlighted for explosive profit growth outpacing revenue, with capacity expansion driving future earnings.

7d -6.5% 30d in 12d90d in 72d
2026-08-22Shilpa MedicareSHILPAMED.NS▲ up

2 Pharma Stocks With Bigger Growth Ahead!

Shilpa Medicare seeing strong growth in formulations, biologics and an upcoming product pipeline, with bigger growth ahead.

7d +10.9% 30d in 7d90d in 67d
2026-08-22Sakar HealthcareSAKAR.NS▲ up

2 Pharma Stocks With Bigger Growth Ahead!

Sakar Healthcare's future growth story looks stronger than its past, driven by scaling oncology, dossiers, approvals and exports.

7d -4.0% 30d in 7d90d in 67d